PCN114 COST-EFFECTIVENESS ANALYSIS OF PEMETREXED/CISPLATIN IN THE FIRST-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER IN ITALY- RESULTS FOR THE ADENOCARCINOMA HISTOLOGY SUB-POPULATION
Oct 1, 2009, 00:00 AM
10.1016/S1098-3015(10)74365-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)74365-5/fulltext
Section Title :
Section Order :
291
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74365-5&doi=10.1016/S1098-3015(10)74365-5